Unless previously surgically sterilized, agrees to use an effective method of birth control (e.g., abstinence, intrauterine contraceptive device, oral contraceptives, diaphragm or condom in combination with contraceptive jelly, cream or foam, Norplant® or DepoProvera®) beginning 30 days before the first study injection and continuing through 60 days after the final study injection [clinicaltrials_resource:ca24ca767349d1fbf7151e7257180679]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Unless previously surgically sterilized, agrees to use an effective method of birth control (e.g., abstinence, intrauterine contraceptive device, oral contraceptives, diaphragm or condom in combination with contraceptive jelly, cream or foam, Norplant® or DepoProvera®) beginning 30 days before the first study injection and continuing through 60 days after the final study injection [clinicaltrials_resource:ca24ca767349d1fbf7151e7257180679]
Bio2RDF identifier
ca24ca767349d1fbf7151e7257180679
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ca24ca767349d1fbf7151e7257180679
identifier
clinicaltrials_resource:ca24ca767349d1fbf7151e7257180679
title
Unless previously surgically s ...... fter the final study injection
@en
type
label
Unless previously surgically s ...... 4ca767349d1fbf7151e7257180679]
@en